Adam Lamble

10PUBLICATIONS

71CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)HaematologyEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 12, 2026

Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

|Feb 17, 2026

CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.

Alexander W Rankin, Regina M Myers, Adam J Lamble

|Jan 09, 2026

Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.

Sharon M Castellino, Hongli Li, Alex F Herrera

|Dec 10, 2025

Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statement.

Adam Lamble, Sandra D Bohling, Kara L Davis

|Aug 19, 2025

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Swati Naik, Richard Aplenc, Susanne H C Baumeister

|Apr 28, 2025

Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Benjamin J Huang, Lauren K Meyer, Todd A Alonzo

Pageof 2

Frequent Collaborators

Nirali N Shah

Regina M Myers

Michael A Pulsipher

Susan R Rheingold

Alexandra E Kovach

Brent Wood

Constance M Yuan

Vinodh Pillai

Daniel W Lee

Patrick A Brown

Frequent Collaborators

Nirali N Shah

Regina M Myers

Michael A Pulsipher

Susan R Rheingold